HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amita Aggarwal Selected Research

Systemic Lupus Erythematosus (Libman-Sacks Disease)

4/2022Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10.
1/2022Catatonia in systemic lupus erythematosus: case based review.
1/2022International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis.
11/2020Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
6/2020Nuclear magnetic resonance-based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis.
5/2020Impact of endogenous stress on albumin structure in systemic lupus erythematosus (SLE) patients.
1/2016Ovarian Insufficiency is Major Short-term Toxicity in Systemic Lupus Erythematosus Patients Treated with Cyclophosphamide.
9/2015Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
6/2008Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.
7/2007Antinuclear antibodies by indirect immunofluorescence : optimum screening dilution for diagnosis of systemic lupus erythematosus.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Amita Aggarwal Research Topics

Disease

28Rheumatoid Arthritis
12/2021 - 05/2002
25Arthritis (Polyarthritis)
11/2021 - 07/2005
20Juvenile Arthritis (Juvenile Idiopathic Arthritis)
12/2019 - 08/2002
14Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2022 - 11/2003
10Infections
01/2022 - 06/2008
9Lupus Nephritis
01/2022 - 09/2015
8Inflammation (Inflammations)
05/2021 - 06/2007
7Reactive Arthritis (Reiter Disease)
01/2021 - 01/2003
7Ankylosing Spondylitis
07/2019 - 05/2008
6Rheumatic Diseases (Rheumatism)
12/2021 - 10/2002
6Spondylarthropathies
06/2016 - 01/2003
3Tuberculosis (Tuberculoses)
12/2021 - 01/2016
3Latent Tuberculosis
01/2021 - 01/2018
3Hypertension (High Blood Pressure)
01/2021 - 08/2007
3Fever (Fevers)
01/2021 - 03/2011
3Autoimmune Diseases (Autoimmune Disease)
03/2016 - 11/2009
3Pain (Aches)
11/2015 - 07/2006
2Back Pain (Backache)
12/2021 - 10/2008
2Dermatomyositis (Dermatopolymyositis)
04/2021 - 02/2009
2Vasculitis (Vasculitides)
12/2020 - 06/2017
2Pancytopenia
07/2017 - 01/2007
2Septic Shock (Toxic Shock Syndrome)
12/2016 - 03/2015
2Sepsis (Septicemia)
12/2016 - 03/2015
2Critical Illness (Critically Ill)
12/2016 - 03/2015
2Psoriatic Arthritis
10/2016 - 07/2004
2Hematuria
01/2016 - 05/2012
2Cicatrix (Scar)
05/2015 - 01/2013
2Fatigue
11/2014 - 11/2009
2Osteoarthritis
03/2008 - 11/2007
2Necrosis
06/2007 - 10/2006
1Schizophrenia (Dementia Praecox)
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Encephalitis (Encephalitis, Rasmussen)
01/2022
1Cytopenia
11/2021
1Bursitis (Adhesive Capsulitis)
04/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2021
1Polymyositis
04/2021
1Myelitis
03/2021

Drug/Important Bio-Agent (IBA)

18CytokinesIBA
01/2021 - 08/2002
17Methotrexate (Mexate)FDA LinkGeneric
12/2021 - 05/2002
11Biomarkers (Surrogate Marker)IBA
12/2021 - 02/2006
8AutoantibodiesIBA
01/2021 - 10/2002
8LigandsIBA
01/2020 - 03/2008
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 11/2002
6Pharmaceutical PreparationsIBA
12/2021 - 05/2002
6ametantrone (HAQ)IBA
11/2021 - 07/2006
6AntigensIBA
01/2021 - 11/2003
6Proteins (Proteins, Gene)FDA Link
11/2020 - 10/2006
6AntibodiesIBA
11/2020 - 11/2003
6Interleukin-17 (Interleukin 17)IBA
10/2017 - 11/2007
6Interleukin-6 (Interleukin 6)IBA
06/2011 - 05/2003
5CreatinineIBA
03/2021 - 05/2012
5Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 03/2011
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 09/2002
5Matrix Metalloproteinases (MMPs)IBA
11/2011 - 06/2007
4SteroidsIBA
01/2022 - 01/2013
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 06/2007
3Antirheumatic Agents (DMARD)IBA
12/2021 - 03/2019
3Immunoglobulin A (IgA)IBA
01/2021 - 05/2006
3TenascinIBA
01/2020 - 05/2015
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
06/2017 - 10/2002
3Rheumatoid FactorIBA
10/2016 - 10/2002
3Membrane Proteins (Integral Membrane Proteins)IBA
02/2013 - 01/2005
3Antinuclear AntibodiesIBA
03/2011 - 07/2007
2O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
12/2021 - 11/2015
2Adenosine (Adenocard)FDA LinkGeneric
05/2021 - 08/2019
2Ligases (Synthetase)IBA
04/2021 - 09/2020
2Tuberculin (PPD)IBA
01/2021 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
11/2020 - 01/2019
2GlucocorticoidsIBA
09/2020 - 04/2013
2Anti-Bacterial Agents (Antibiotics)IBA
12/2019 - 05/2015
2Biological ProductsIBA
01/2019 - 04/2016
2RNA (Ribonucleic Acid)IBA
01/2019 - 02/2009
2Cytochrome P-450 CYP2C19IBA
10/2017 - 04/2007
2Hemoglobins (Hemoglobin)IBA
07/2017 - 10/2006
2Toll-Like Receptor 4IBA
12/2016 - 05/2015
2ProcalcitoninIBA
12/2016 - 03/2015
2Ferritins (Ferritin)IBA
10/2014 - 10/2006
2Immunoglobulin M (IgM)IBA
09/2014 - 02/2007
2Peptides (Polypeptides)IBA
09/2013 - 02/2013
2Interleukin-12 (IL 12)IBA
02/2012 - 06/2008
2Tissue Inhibitor of MetalloproteinasesIBA
11/2011 - 03/2008
2Interleukin-10 (Interleukin 10)IBA
07/2010 - 11/2007
2InterleukinsIBA
06/2008 - 07/2005
2InterferonsIBA
11/2007 - 07/2005
2GoldIBA
06/2007 - 02/2004
2EnzymesIBA
06/2007 - 05/2006
1Interferon Type IIBA
04/2022
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022
1N-Methylaspartate (NMDA)IBA
01/2022
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022
1MethylprednisoloneFDA LinkGeneric
01/2022
1Adenosine DeaminaseIBA
12/2021
1Transforming Growth Factor-beta Type II ReceptorIBA
05/2021
1Rituximab (Mabthera)FDA Link
04/2021
1SS-A antibodiesIBA
03/2021

Therapy/Procedure

17Therapeutics
12/2021 - 06/2006
1Drug Tapering
11/2021
1Physical Therapy Modalities (Physical Therapy Technique)
04/2021
1Aftercare (After-Treatment)
03/2021